Prognostic value of preoperative Ca125 and Tag72 serum levels and their correlation to disease relapse and survival in endometrial cancer

Objective To evaluate preoperative serum levels of Ca125 and Tag72–4 tumour markers and investigate if abnormal levels correlate to mortality and disease-free survival.

Retrospective observational study of a cohort of 282 women (mean age 62.3, SD 10.5 years) with primary endometrial cancer included all consecutive cases treated in a tertiary Gynaecological oncology Center. Excluded cases with other cancer or previous cancer treatment, major abdominal pathology or inflammation, endometriosis. Preoperative serum Tag72 and Ca125 levels were determined and evaluated in relation to disease-free survival (DFS) and disease-specific overall survival (DOS).

Raised Ca125 correlates to worse overall disease-specific survival (66.1 vs 87.8 months, p = 0.021) and Tag72 correlates to shorter disease-free survival (69.2 vs 67.3 months, p = 0.021) and higher recurrence rate (13.5 vs 6 %, p = 0.021). When both Ca125 and Tag72 are abnormal DFS and DOS are worse. 93.3 % (72.3 months) vs 82.4 %, (61.3 months) p = 0.018 and 96.3 % (74.8 months) vs 88.2 %, (65.9 months) p = 0.021, respectively.

This study enhances the value of preoperative tumour markers and their prognostic value. Ca125 and Tag72 appear to be good predictors of poor prognosis in patients with endometrial cancer. Similar content being viewed by others

Amant F, Moerman P, Neven P et al (2005) Endometrial cancer. Lancet 366:491–505 Ferlay J, Shin HR, Bray F et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917. doi:10.1002/ijc.25516 Sorosky JI (2012) Endometrial cancer. Obstet Gynecol 120(2 Pt 1):383–397 Ferlay J, Shin HR, Bray F (2010) GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide. Lyon, France: International Agency for Research on Cancer: IARC Cancer Base No. 10 Sorosky JI (2008) Endometrial cancer. Obstet Gynecol 111(2 Pt 1):436–447 Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, Sessa C, ESMO Guidelines Working Group (2011) Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 22(Suppl 6):vi35–vi39 Cancer Research UK. http://www.cancerresearchuk.org/cancer-info/cancerstats/types/uterus Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL, Heintz AP, Ngan HY, Pecorelli S (2006) Carcinoma of the corpus uteri. FIGO 26th Annual Report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 95(Suppl 1):S105–S143 Niloff JM, Klug TL, Schaetzl E, Zurawski VR Jr, Knapp RC, Bast RC Jr (1984) Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix. Am J Obstet Gynecol 148:1057–1058 Duk JM, Aalders JG, Fleuren GJ, de Bruijn HW (1986) CA 125: a useful marker in endometrial carcinoma. Am J Obstet Gynecol 155:1097–1102 Patsner B, Mann WJ, Cohen H, Loesch M (1988) Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma. Am J Obstet Gynecol 158:399–402 Soper JT, Berchuck A, Olt GJ, Soisson AP, Clarke-Pearson DL, Bast RC Jr (1990) Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma. Am J Obstet Gynecol 163:1204–1209 Sood AK, Buller RE, Burger RA, Dawson JD, Sorosky JI, Berman M (1997) Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome. Obstet Gynecol 90:441–447 Cherchi PL, Dessole S, Ruiu GA, Ambrosini G, Farina M, Capobianco G, Ambrosini A (1999) The value of serum CA 125 and association CA 125/CA 19-9 in endometrial carcinoma. Eur J Gynaecol Oncol 20(4):315–317 Dotters DJ, Preoperative CA (2000) 125 in endometrial cancer: is it useful? Am J Obstet Gynecol 182:1328–1334 Ebina Y, Sakuragi N, Hareyama H, Todo Y, Nomura E, Takeda M et al (2002) Para-aortic lymph node metastasis in relation to serum CA 125 levels and nuclear grade in endometrial carcinoma. Acta Obstet Gynecol Scand 81:458–465 Hsieh CH, ChangChien CC, Lin H, Huang EY, Huang CC, Lan KC et al (2002) Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer? Gynecol Oncol 86:28–33 Todo Y, Sakuragi N, Nishida R, Yamada T, Ebina Y, Yamamoto R et al (2003) Combined use of magnetic resonance imaging, CA 125 assay, histologic type, and histologic grade in the prediction of lymph node metastasis in endometrial carcinoma. Am J Obstet Gynecol 188:1265–1272 Jhang H, Chuang L, Visintainer P, Ramaswamy G (2003) CA 125 levels in the preoperative assessment of advanced-stage uterine cancer. Am J Obstet Gynecol 188(5):1195–1197 Santala M, Talvensaari-Mattila A, Kauppila A (2003) Peritoneal cytology and preoperative serum CA 125 level are important prognostic indicators of overall survival in advanced endometrial cancer. Anticancer Res 23(3C):3097–3103 Powell JL, Hill KA, Shiro BC, Diehl SJ, Gajewski WH (2005) Preoperative serum CA-125 levels in treating endometrial cancer. J Reprod Med 50(8):585–590 Chung HH, Kim JW, Park NH, Song YS, Kang SB, Lee HP (2006) Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer. Acta Obstet Gynecol Scand 85:1501–1505 Todo Y, Okamoto K, Hayashi M, Minobe S, Nomura E, Hareyama H, Takeda M, Ebina Y, Watari H, Sakuragi N (2007) A validation study of a scoring system to estimate the risk of lymph node metastasis for patients with endometrial cancer for tailoring the indication of lymphadenectomy. Gynecol Oncol 104(3):623–628 Han SS, Lee SH, Kim DH, Kim JW, Park NH, Kang SB et al (2010) Evaluation of preoperative criteria used to predict lymph node metastasis in endometrial cancer. Acta Obstet Gynecol Scand 89:168–174 Kim HS, Park CY, Lee JM, Lee JK, Cho CH, Kim SM et al (2010) Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: a multi-center study. Gynecol Oncol 118:283–288 Lee JY, Jung DC, Park SH, Lim MC, Seo SS, Park SY et al (2010) Preoperative prediction model of lymph node metastasis in endometrial cancer. Int J Gynecol Cancer 20:1350–1355 Sebastianelli A, Renaud MC, Grégoire J, Roy M, Plante M (2010) Preoperative CA 125 tumour marker in endometrial cancer: correlation with advanced stage disease. J Obstet Gynaecol Can 32(9):856–860 Yoon JH, Yoo SC, Kim WY, Chang SJ, Chang KH, Ryu HS (2010) Para-aortic lymphadenectomy in the management of preoperative grade 1 endometrial cancer confined to the uterine corpus. Ann Surg Oncol 17:3234–3240 Chen YL, Huang CY, Chien TY, Huang SH, Wu CJ, Ho CM (2011) Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer. Aust N Z J Obstet Gynaecol 51:397–402 Goksedef BP, Gorgen H, Baran SY, Api M, Cetin A (2011) Preoperative serum CA 125 level as a predictor for metastasis and survival in endometrioid endometrial cancer. J Obstet Gynaecol Can 33(8):844–850 Gupta D, Gunter MJ, Yang K, Lee S, Zuckerwise L, Chen LM, Goldberg GL, Huang GS (2011) Performance of serum CA125 as a prognostic biomarker in patients with uterine papillary serous carcinoma. Int J Gynecol Cancer 21(3):529–534 Roelofsen T, Mingels M, Hendriks JC, Samlal RA, Snijders MP, Aalders AL, Bulten J, van Ham MA, Massuger LF (2012) Preoperative CA-125 predicts extra-uterine disease and survival in uterine papillary serous carcinoma patients. Int J Biol Markers 27(3):e263–e271 Kang S, Kang WD, Chung HH, Jeong DH, Seo SS, Lee JM et al (2012) Preoperative identification of a low-risk group for lymph node metastasis in endometrial cancer: a Korean Gynecologic Oncology Group study. J Clin Oncol 30:1329–1334 Nicklin J, Janda M, Gebski V, Jobling T, Land R, Manolitsas T, McCartney A, Nascimento M, Perrin L, Baker JF, Obermair A, LACE Trial Investigators (2012) The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer. Int J Cancer 131(4):885–890 Yildiz A, Yetimalar H, Kasap B, Aydin C, Tatar S, Soylu F, Yildiz FS (2012) Preoperative serum CA 125 level in the prediction of the stage of disease in endometrial carcinoma. Eur J Obstet Gynecol Reprod Biol 164(2):191–195 Antonsen SL, Høgdall E, Christensen IJ, Lydolph M, Tabor A, Loft Jakobsen A, Fagö-Olsen CL, Andersen ES, Jochumsen K, Høgdall C (2013) HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET). Acta Obstet Gynecol Scand 92(11):1313–1322 Saarelainen SK, Peltonen N, Lehtimäki T, Perheentupa A, Vuento MH, Mäenpää JU (2013) Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinoma. Am J Obstet Gynecol 209(2):142.e1–142.e6 Chao A, Tang YH, Lai CH, Chang CJ, Chang SC, Wu TI, Hsueh S, Wang CJ, Chou HH, Chang TC (2013) Potential of an age-stratified CA125 cut-off value to improve the prognostic classification of patients with endometrial cancer. Gynecol Oncol 129(3):500–504 Hareyama H, Sakuragi N, Makinoda S, Fujimoto S (1996) Serum and tissue measurements of CA72-4 in patients with endometrial carcinoma. J Clin Pathol 49(12):967–970 Neubauer NL, Lurain JR. (2011) The role of lymphadenectomy in surgical staging of endometrial cancer. Int J Surg Oncol 2011:814649 Conflict of interest All the authors declare that they have no conflict of interest. Author information Authors and Affiliations Corresponding author Rights and permissions About this article Cite this article Myriokefalitaki, E., Vorgias, G., Vlahos, G. et al. Prognostic value of preoperative Ca125 and Tag72 serum levels and their correlation to disease relapse and survival in endometrial cancer. Arch Gynecol Obstet 292, 647–654 (2015). https://doi.org/10.1007/s00404-015-3675-4 Received: Accepted: Published: Issue date: DOI: https://doi.org/10.1007/s00404-015-3675-4